| View |
|
DR-XY36261
|
Glucose + Amino Acids + Electrolytes + Purified Soy Bean Oil
|
Kabiven Peripheral
|
(See reverse Formulation)
|
Emulsion For Iv Infusion
|
Parenteral Nutrition
|
Fresenius Kabi AB
|
Sweden
|
Renewal
|
02 July 2024
|
14 July 2029
|
| View |
|
DR-XY36266
|
Dexketoprofen (as trometamol)
|
Ketesse
|
25 mg/mL (50 mg/2mL)
|
Solution for Injection or
Concentrate for Solution for Infusion (I.M./I.V.)
|
Anti-Inflammatory and Anti-Rheumatic Product Non-Steroid
|
A.Menarini Manufacturing Logistics and Services
S.r.l.
|
Italy
|
Renewal
|
28 May 2024
|
17 July 2029
|
| View |
|
DR-XY36275
|
Dexketoprofen (as Trometamol)
|
Ketesse
|
25mg
|
Film-Coated Tablet
|
Non-Steroidal Antiinflammatory Drug (NSAID)
(Propionic Acid Derivative)
|
A. Menarini Manufacturing Logistics and Services
S.R.L.
|
Italy
|
Initial (from Monitored Release Status)
|
17 May 2022
|
29 May 2027
|
| View |
|
DR-XY36278
|
Ciprofloxacin (As Hydrochloride)
|
Ceprotron
|
500 mg
|
Tablet
|
-
|
Sydenham Laboratories, Inc.
|
Philippines
|
-
|
03 February 2021
|
16 July 2026
|
| View |
DR-XY36290_PI_01.pdf
|
DR-XY36290
|
Olmesartan (as medoxomil) + Amlodipine (as besilate)
|
Alzor Ccb
|
20 mg/ 10 mg
|
Film-Coated Tablet
|
Angiotensin II receptor blocker/ Calcium channel
blocker
|
Ajanta Pharma Limited
|
India
|
Monitored Release
|
11 March 2022
|
21 July 2025
|
| View |
DR-XY36291_PI_01.pdf
|
DR-XY36291
|
Olmesartan medoxomil + Amlodipine (as besilate)
|
Alzor CCB
|
20mg/5mg
|
Film-Coated Tablet
|
-
|
Ajanta Pharma Limited.
|
India
|
Initial (Variation)
|
20 December 2023
|
20 December 2028
|
| View |
DR-XY36293_PI_01.pdf
|
DR-XY36293
|
Pioglitazone (as Hydrochloride) + Glimepiride
|
Asenza Plus
|
15mg/2mg
|
Tablet
|
-
|
Ajanta Pharma Limited
|
India
|
-
|
12 April 2022
|
21 July 2025
|
| View |
DR-XY36294_PI_01.pdf
|
DR-XY36294
|
Pioglitazone (as Hydrochloride) + Glimepiride
|
Asenza Plus
|
30mg/2mg
|
Tablet
|
Antidiabetic
|
Ajanta Pharma Limited
|
India
|
Initial (from Monitored Release)
|
12 April 2022
|
21 July 2025
|
| View |
|
DR-XY36314
|
Aciclovir
|
Zealor
|
400 mg
|
Tablet
|
Antiviral
|
Flamingo Pharmaceuticals Ltd.
|
India
|
Renewal
|
21 April 2024
|
23 July 2029
|
| View |
|
DR-XY36319
|
Silver Sulfadiazine
|
Silvederma
|
1 g/100 g (1% w/w)
|
Cream
|
Antibacterial
|
Laboratorio Aldo Union, S.L.
|
Spain
|
Renewal
|
31 January 2024
|
23 July 2029
|
| View |
|
DR-XY36320
|
Thiamine Mononitrate (Vitamin B1) / Pyridoxine Hydrochloride (Vitamin B6) / Cyanocobalamin (Vitamin B12)
|
Polynerv 1000
|
250 mg/250 mg/1 mg
|
Film-Coated Tablet
|
Vitamins
|
Lloyd Laboratores, Inc.
|
Philippines
|
Renewal
|
27 May 2024
|
23 July 2029
|
| View |
|
DR-XY36328
|
Perindopril (as Erbumine)
|
Benace
|
4mg
|
Film-Coated Tablet
|
Angiotensin Converting Enzyme (ACE) Inhibitor
|
Lloyd Laboratores, Inc.
|
Philippines
|
Renewal
|
24 June 2024
|
24 July 2029
|
| View |
|
DR-XY36329
|
Losartan (As Potassium) / Hydrochlorothiazide
|
Zarnat Max
|
100 mg/25 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal (Re-issuance)
|
02 August 2022
|
24 July 2025
|
| View |
|
DR-XY36352
|
Sterile Water For Injection
|
None
|
None
|
Solution for Injection
|
PARENTERAL
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
Automatic Renewal
|
21 March 2022
|
29 July 2027
|
| View |
|
DR-XY36358
|
Cefradine
|
Zefadin
|
500mg
|
Powder for Injection (IM/IV)
|
Antibacterial
|
Singapore Pharmawealth Lifesciences, Inc.
|
Philippines
|
Renewal
|
29 May 2024
|
29 July 2029
|
| View |
|
DR-XY36359
|
Gadobenate dimeglumine
|
MultiHance
|
529mg/mL (equivalent to Gadobenic acid 334 mg + Meglumine 195 mg/mL)
|
Solution For IV Injection
|
Diagnostic agent
|
Patheon Italia S.p.A.
|
Italy
|
Renewal
|
25 July 2024
|
29 July 2029
|
| View |
|
DR-XY36360
|
Levofloxacin
|
Levoxin
|
5 mg/mL
|
Solution For Iv Infusion
|
Antibacterial (Fluoroquinolone)
|
Amanta Healthcare Ltd.
|
India
|
Renewal
|
21 May 2024
|
29 July 2029
|
| View |
|
DR-XY36361
|
Cefradine
|
Zefadin
|
1g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Singapore Pharmawealth Lifesciences, Inc.
|
Philippines
|
Renewal
|
19 May 2024
|
29 July 2029
|
| View |
|
DR-XY36367
|
Cefuroxime Sodium
|
GEROZEF
|
750 mg
|
Powder For Injection
|
Antibacterial (Cephalosporins)
|
Shanxi Shuguang Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
14 March 2022
|
29 July 2027
|
| View |
|
DR-XY36369
|
Otilonium bromide
|
Spasmomen
|
40mg
|
Film coated tablet
|
Antispasmodic
|
Berlin Chemie AG
|
Germany
|
Automatic Renewal
|
16 February 2021
|
18 February 2026
|